by admin | Mar 9, 2022 | Uncategorized
ReNerve Ltd (ReNerve) today announced that it has received market clearance from the FDA for its NervAlign® Nerve Cuff medical device. This means that the company can now market and sell the product in the United States. The NervAlign® Nerve Cuff is a Class II medical...
by admin | Feb 10, 2022 | Uncategorized
ReNerve Ltd (ReNerve) today announced that it has entered into an agreement with Emerging Surgical in San Diego for the launch, promotion and sales of its NervAlign® Nerve Cuff. ReNerve has filed with the FDA for marketing clearance for its NervAlign® Nerve Cuff and...
by admin | Jul 16, 2021 | Uncategorized
ReNerve has partnered with VivaZome Therapeutics to develop therapeutic solutions for spinal cord repair. The collaboration aims to combine ReNerve’s NervAlign® Nerve Cuff, which is expected to receive marketing approval from the FDA by early 2022, with VivaZome’s...
by admin | Jul 11, 2021 | Uncategorized
ReNerve showcased its novel tissue-based products at the Royal Australasian College of Surgeons’ Annual Scientific Congress, held in Melbourne in May. The conference, which had both face-to-face and virtual attendees, is the largest multi-disciplinary meeting held in...
